FindTrial
Sign In

Precise clinical treatment for Adenocarcinoma of esophagogastric junction: a multicenter prospective real-world study

Precise clinical treatment for Adenocarcinoma of esophagogastric junction: a multicenter prospective real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026131
Enrollment
Unknown
Registered
2019-09-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of esophagogastric junction

Interventions

Case series:none

Sponsors

Guangdong Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Adenocarcinoma was histologically confirmed; 2. The tumor center is within 5cm above and below the esophagogastric junction and crosses or involves the esophagogastric junction.

Exclusion criteria

Exclusion criteria: 1. Squamous carcinoma or adenosquamous carcinoma; 2. Tumors do not crosses or involves the esophagogastric junction.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Countries

China

Contacts

Public ContactYong Li

Guangdong Provincial People's Hospital

yuan821007@126.com+86 020 83827812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026